These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 15694207

  • 1. The PLP mutants from mouse to man.
    Duncan ID.
    J Neurol Sci; 2005 Feb 15; 228(2):204-5. PubMed ID: 15694207
    [No Abstract] [Full Text] [Related]

  • 2. Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.
    Garbern JY.
    J Neurol Sci; 2005 Feb 15; 228(2):201-3. PubMed ID: 15694206
    [No Abstract] [Full Text] [Related]

  • 3. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
    McLaughlin M, Barrie JA, Karim S, Montague P, Edgar JM, Kirkham D, Thomson CE, Griffiths IR.
    Glia; 2006 May 15; 53(7):715-22. PubMed ID: 16506223
    [Abstract] [Full Text] [Related]

  • 4. A brief history of Pelizaeus-Merzbacher disease and proteolipid protein.
    Koeppen AH.
    J Neurol Sci; 2005 Feb 15; 228(2):198-200. PubMed ID: 15694205
    [No Abstract] [Full Text] [Related]

  • 5. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
    Karim SA, Barrie JA, McCulloch MC, Montague P, Edgar JM, Iden DL, Anderson TJ, Nave KA, Griffiths IR, McLaughlin M.
    Glia; 2010 Nov 01; 58(14):1727-38. PubMed ID: 20629189
    [Abstract] [Full Text] [Related]

  • 6. Genetic background determines phenotypic severity of the Plp rumpshaker mutation.
    Al-Saktawi K, McLaughlin M, Klugmann M, Schneider A, Barrie JA, McCulloch MC, Montague P, Kirkham D, Nave KA, Griffiths IR.
    J Neurosci Res; 2003 Apr 01; 72(1):12-24. PubMed ID: 12645075
    [Abstract] [Full Text] [Related]

  • 7. Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis.
    Garbern JY.
    Cell Mol Life Sci; 2007 Jan 01; 64(1):50-65. PubMed ID: 17115121
    [Abstract] [Full Text] [Related]

  • 8. Disrupted compaction of CNS myelin in an OSP/Claudin-11 and PLP/DM20 double knockout mouse.
    Chow E, Mottahedeh J, Prins M, Ridder W, Nusinowitz S, Bronstein JM.
    Mol Cell Neurosci; 2005 Jul 01; 29(3):405-13. PubMed ID: 15886014
    [Abstract] [Full Text] [Related]

  • 9. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.
    Henneke M, Combes P, Diekmann S, Bertini E, Brockmann K, Burlina AP, Kaiser J, Ohlenbusch A, Plecko B, Rodriguez D, Boespflug-Tanguy O, Gärtner J.
    Neurology; 2008 Mar 04; 70(10):748-54. PubMed ID: 18094336
    [Abstract] [Full Text] [Related]

  • 10. Rabbit paralytic tremor phenotype--a plp1 gene mutation as a model of human Pelizaeus-Merzbacher disease.
    Sypecka J, Domańska-Janik K.
    Acta Neurobiol Exp (Wars); 2005 Mar 04; 65(2):221-9. PubMed ID: 15960310
    [Abstract] [Full Text] [Related]

  • 11. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA, Barrie JA, McCulloch MC, Montague P, Edgar JM, Kirkham D, Anderson TJ, Nave KA, Griffiths IR, McLaughlin M.
    Glia; 2007 Mar 04; 55(4):341-51. PubMed ID: 17133418
    [Abstract] [Full Text] [Related]

  • 12. A severe connatal form of Pelizaeus Merzbacher disease in a Czech boy caused by a novel mutation (725C>A, Ala242Glu) at the 'jimpy(msd) codon' in the PLP gene.
    Seeman P, Paderova K, Benes V, Sistermans EA.
    Int J Mol Med; 2002 Feb 04; 9(2):125-9. PubMed ID: 11786921
    [Abstract] [Full Text] [Related]

  • 13. Aberrant trafficking of a proteolipid protein in a mild Pelizaeus-Merzbacher disease.
    Koizume S, Takizawa S, Fujita K, Aida N, Yamashita S, Miyagi Y, Osaka H.
    Neuroscience; 2006 Sep 15; 141(4):1861-9. PubMed ID: 16844304
    [Abstract] [Full Text] [Related]

  • 14. Myelin mishaps.
    Barkovich AJ.
    Ann Neurol; 2007 Aug 15; 62(2):107-9. PubMed ID: 17683086
    [No Abstract] [Full Text] [Related]

  • 15. Effect of curcumin in a mouse model of Pelizaeus-Merzbacher disease.
    Yu LH, Morimura T, Numata Y, Yamamoto R, Inoue N, Antalfy B, Goto Y, Deguchi K, Osaka H, Inoue K.
    Mol Genet Metab; 2012 May 15; 106(1):108-14. PubMed ID: 22436581
    [Abstract] [Full Text] [Related]

  • 16. Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI, Thomson G, Penderis J, Edgar JM.
    J Anat; 2011 Jul 15; 219(1):33-43. PubMed ID: 21401588
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a PLP-overexpressing transgenic rat, a model for the connatal form of Pelizaeus-Merzbacher disease.
    Mayer JA, Larsen EC, Kondo Y, Duncan ID.
    Neurobiol Dis; 2011 Nov 15; 44(2):231-8. PubMed ID: 21784154
    [Abstract] [Full Text] [Related]

  • 18. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
    Woodward KJ.
    Expert Rev Mol Med; 2008 May 19; 10():e14. PubMed ID: 18485258
    [Abstract] [Full Text] [Related]

  • 19. Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat.
    Miller MJ, Haxhiu MA, Georgiadis P, Gudz TI, Kangas CD, Macklin WB.
    J Neurosci; 2003 Mar 15; 23(6):2265-73. PubMed ID: 12657685
    [Abstract] [Full Text] [Related]

  • 20. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
    Inoue K.
    Adv Exp Med Biol; 2019 Mar 15; 1190():201-216. PubMed ID: 31760646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.